NDC 70518-3862 – Buprenorphine hydrochloride and naloxone hydrochloride dihydrate

Buprenorphine Hydrochloride 2 mg/1; Naloxone Hydrochloride Dihydrate .5 mg/1 · Tablet · Sublingual

Human Prescription Drug DEA schedule CIII

Product NDC70518-3862

Product details

Brand name
Buprenorphine hydrochloride and naloxone hydrochloride dihydrate
Generic name
Buprenorphine hydrochloride and naloxone hydrochloride dihydrate
Labeler
REMEDYREPACK INC.
Dosage form
Tablet
Route
Sublingual
Marketing category
ANDA · ANDA203326
Marketed since
September 15, 2023
Listing expires
December 31, 2027
Pharmacologic class
Opioid Antagonist; Partial Opioid Agonist

Active ingredients

Uses, dosage, side effects and warnings for BUPRENORPHINE HYDROCHLORIDE and NALOXONE HYDROCHLORIDE DIHYDRATE →

Package NDC codes (1)

Package NDCDescriptionSince
70518-3862-030 TABLET in 1 BLISTER PACK (70518-3862-0)Sep 15, 2023

Other BUPRENORPHINE HYDROCHLORIDE and NALOXONE HYDROCHLORIDE DIHYDRATE products